Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any amyotrophic lateral sclerosis in which the cause of the disease is a mutation in the FIG4 gene.
Features include always present findings: Amyotrophic lateral sclerosis; and common findings: Bulbar signs. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 1 | Skeletal muscle atrophy |
Muscles |
FIG4 encodes FIG4 phosphoinositide 5-phosphatase (907 aa). Dual specificity phosphatase component of the PI(3,5)P2 regulatory complex which regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Highest expression in Artery Tibial (25.0 TPM) and Brain Frontal Cortex BA9 (22.9 TPM).
Amyotrophic lateral sclerosis type 11 has limited evidence linking it to mutations in the FIG4 gene on chromosome 6.
FIG4 is classified as a druggable target with score 0.0.
Genetic testing for FIG4 is available. Testing is considered research-grade for diagnosis.
Biomarker and diagnostic research for amyotrophic lateral sclerosis type 11 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 common feature.
No clinical trials have been registered for amyotrophic lateral sclerosis type 11.
170 publications have been identified in PubMed for amyotrophic lateral sclerosis type 11. Research spans Basic Science / Preclinical (31%), Review / Meta-Analysis (27%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 53 | 31% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 4:16 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1
Skeletal muscle atrophy |
Research summaries
46 |
27% |
Disease patterns and progression | 27 | 16% |
Clinical study results | 17 | 10% |
Patient case studies | 13 | 8% |
Testing and diagnosis research | 8 | 5% |
New treatment approaches | 5 | 3% |
Other research | 1 | 1% |
Aynaashe A (2026). [PMID: 41621017](https://pubmed.ncbi.nlm.nih.gov/41621017/). *Amino Acids*. [Review / Meta-Analysis]
Ptáček O (2026). [PMID: 41751793](https://pubmed.ncbi.nlm.nih.gov/41751793/). *Int J Mol Sci*. [Review / Meta-Analysis]
Zulhairy-Liong NA (2026). [PMID: 41359433](https://pubmed.ncbi.nlm.nih.gov/41359433/). *Amyotroph Lateral Scler Frontotemporal Degener*. [Basic Science / Preclinical]
Lu J (2026). [PMID: 41277110](https://pubmed.ncbi.nlm.nih.gov/41277110/). *Autophagy*. [Review / Meta-Analysis]
Saadat A (2026). [PMID: 42240799](https://pubmed.ncbi.nlm.nih.gov/42240799/). *Mol Neurobiol*. [Basic Science / Preclinical]
Carletta O (2026). [PMID: 40908789](https://pubmed.ncbi.nlm.nih.gov/40908789/). *Brain*. [Epidemiology / Natural History]
Chalitsios CV (2026). [PMID: 41165081](https://pubmed.ncbi.nlm.nih.gov/41165081/). *Ann Neurol*. [Basic Science / Preclinical]
Wong B (2026). [PMID: 42242586](https://pubmed.ncbi.nlm.nih.gov/42242586/). *Neurobiol Dis*. [Basic Science / Preclinical]
Herrmann C (2026). [PMID: 42197088](https://pubmed.ncbi.nlm.nih.gov/42197088/). *Nutrients*. [Review / Meta-Analysis]
Michels S (2026). [PMID: 42222887](https://pubmed.ncbi.nlm.nih.gov/42222887/). *J Clin Invest*. [Diagnostic / Biomarker]